West Pharmaceutical Services, I vs Align Technology, Inc.
A head-to-head of West Pharmaceutical Services, I (WST) and Align Technology, Inc. (ALGN) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | WST | ALGN |
|---|---|---|
| Market Cap | $22.35B | $11.58B |
| P/E (TTM) | 42.20 | 27.13 |
| Forward P/E | 34.01 | 12.99 |
| P/S | 6.48 | 3.33 |
| P/B | 7.66 | 2.79 |
| EV/EBITDA | 24.06 | 14.35 |
| Dividend Yield | 0.27% | — |
| Profit Margin | 16.85% | 10.50% |
| Gross Margin | 35.89% | 67.19% |
| Operating Margin | 20.09% | 14.51% |
| Revenue Growth (YoY) | +21.01% | +6.21% |
| FCF Yield | 2.19% | 4.27% |
| Debt / Equity | 7.50 | 2.80 |
| Current Ratio | 2.71 | 1.39 |
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.